Olema Pharmaceuticals (OLMA) Earnings Date & Reports
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OLMA is expected to report earnings to rise 5.39% to -53 cents per share on May 13
Q1'25
Est.
$-0.54
Q4'24
Beat
by $0.13
Q3'24
Missed
by $0.03
Q2'24
Est.
$-0.54
Q1'24
Missed
by $0.02
The last earnings report on March 18 showed earnings per share of -50 cents, beating the estimate of -63 cents. With 2.20M shares outstanding, the current market capitalization sits at 227.55M.